218 related articles for article (PubMed ID: 36859742)
1. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.
Shahbazi R; Jafari-Gharabaghlou D; Mirjafary Z; Saeidian H; Zarghami N
Pharmacol Rep; 2023 Apr; 75(2):442-455. PubMed ID: 36859742
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells.
Abdulkareem SJ; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Salmani-Javan E; Toroghi F; Zarghami N
Daru; 2024 Jun; 32(1):133-144. PubMed ID: 38168007
[TBL] [Abstract][Full Text] [Related]
3. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
[TBL] [Abstract][Full Text] [Related]
4. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
[TBL] [Abstract][Full Text] [Related]
6. Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections.
Hemmati J; Chiani M; Chegini Z; Seifalian A; Arabestani MR
Sci Rep; 2024 Jun; 14(1):13362. PubMed ID: 38862754
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells.
Firouzi Amandi A; Jokar E; Eslami M; Dadashpour M; Rezaie M; Yazdani Y; Nejati B
Med Oncol; 2023 May; 40(6):170. PubMed ID: 37156929
[TBL] [Abstract][Full Text] [Related]
8. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells.
Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N
Front Oncol; 2023; 13():1193708. PubMed ID: 37664043
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
10. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
11. Optimization, physicochemical characterization, and antimicrobial activity of a novel simvastatin nano-niosomal gel against E. coli and S. aureus.
Akbarzadeh I; Keramati M; Azadi A; Afzali E; Shahbazi R; Chiani M; Norouzian D; Bakhshandeh H
Chem Phys Lipids; 2021 Jan; 234():105019. PubMed ID: 33232724
[TBL] [Abstract][Full Text] [Related]
12. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells.
Akbarzadeh I; Saremi Poor A; Yaghmaei S; Norouzian D; Noorbazargan H; Saffar S; Ahangari Cohan R; Bakhshandeh H
Drug Dev Ind Pharm; 2020 Sep; 46(9):1535-1549. PubMed ID: 32808813
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action.
Hassani N; Jafari-Gharabaghlou D; Dadashpour M; Zarghami N
Appl Biochem Biotechnol; 2022 Oct; 194(10):4930-4945. PubMed ID: 35674922
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and
Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
[No Abstract] [Full Text] [Related]
16. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
17. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
18. pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy.
Khodabakhsh F; Bourbour M; Yaraki MT; Bazzazan S; Bakhshandeh H; Ahangari Cohan R; Tan YN
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080186
[TBL] [Abstract][Full Text] [Related]
19. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies.
Amiri S; Pashizeh F; Moeinabadi-Bidgoli K; Eyvazi Y; Akbari T; Salehi Moghaddam Z; Eskandarisani M; Farahmand F; Hafezi Y; Nouri Jevinani H; Seif M; Mousavi-Niri N; Chiani M; Tavakkoli Yaraki M
Environ Res; 2023 Dec; 239(Pt 2):117292. PubMed ID: 37806480
[TBL] [Abstract][Full Text] [Related]
20. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
